DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma

Simona Camero(Sapienza University of Rome), Francesca Megiorni(Sapienza University of Rome)
Cells
October 30, 2021
10.3390/cells10112956
Cited by 27

Related Papers

Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
|Journal of Experimental & Clinical Cancer Research|2015|55
DNMT3B<i>in vitro</i>knocking-down is able to reverse embryonal rhabdomyosarcoma cell phenotype through inhibition of proliferation and induction of myogenic differentiation
|Oncotarget|2016|40
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
|Journal of Cancer Research and Clinical Oncology|2018|35
OTX015 Epi-Drug Exerts Antitumor Effects in Ovarian Cancer Cells by Blocking GNL3-Mediated Radioresistance Mechanisms: Cellular, Molecular and Computational Evidence
|Cancers|2021|19